tbuckley/cabot-search huggingface dataset:
A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1
Authors: Kristin A Rand, Nicola Camp, Alessandro Martino, Eric W. Dean, Daniel J. Serie, Christopher K. Edlund, Donglei Hu, Karen Curtin, Scott Huntsman, David J. Van Den Berg, Anneclaire De Roos, Elizabeth E Brown, Graham G. Giles, John J. Spinelli, Sikander Ailawadhi, Brenda M. Birmann, Angela R Brooks-Wilson, Richard K Severson, Paige M Bracci, Mulugeta Gebregziabher, Michael H. Tomasson, Ann M. Mohrbacher, Guido J. Tricot, Daniele Campa, Thomas Martin, Brian E. Henderson, Maurizio Zangari, Nathaniel Rothman, Stephen Jacob Chanock, Shaji Kumar, Laurence N. Kolonel, Jeffrey Lee Wolf, Graham A Colditz, S. Vincent Rajkumar, Nikhil C. Munshi, Kenneth C. Anderson, Christopher Haiman, David V. Conti, Federico Canzian, Celine M Vachon, Elad Ziv, Wendy Cozen
Journal: Blood (2013)
Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on the First 683 Patients From the European LeukemiaNet Registry
Authors: Reinhard Stauder, Alex Smith, Theo de Witte, Jackie Droste, Pierre Fenaux, Argyris Symeonidis, Eva Hellstrom-Lindberg, Guillermo F Sanz, Jaroslav Cermak, Otilia Georgescu, Ulrich Germing, Marius MacKenzie, Odile Beyne-Rauzy, Luca Malcovati, David Bowen
Journal: Blood (2010)
Multiparametric 18F-Choline PET/MR in childhood and teenage-young adult gliomas: assessment of suspected disease progression
Authors: Valentina Ferrazzoli, Ananth Shankar, Julia V Cockle, Christine Tang, Jamshed Bomanji Francesco Fraioli, Harpreet Hyare
Journal: Neuro-Oncology (2019)

Abstract Aim Evaluation of post-treatment glioma burden remains a significant challenge in childhood, Teenage and Young Adults (TYA). Although amino acid PET impacts on glioma imaging, 18fluoro-Choline Positron Emission Tomography (ChoPET) is more widely available. The aim was to evaluate the utility of ChoPET/MRI for suspected disease progression in childhood and TYA gliomas. Methods 27 consecutive patients with suspected glioma disease progression were evaluated with ChoPET/MR and 59 scans included. Relative cerebral blood volume (rCBV), ADC and SUVmax in enhancing (enh), non-enhancing (ne) tumour volumes and normal appearing white matter (wm) were calculated (rCBVenh, rCBVne, rCBVwm, ADCenh, ADCne, ADCwm, SUVenh, SUVne, SUVwm). Blinded nuclear medicine and neuroradiologist scored the images on tumour probability (1:unlikely-5:definitely). Receiver Operating Characteristic (ROC) analysis considering as gold standard histopathology or clinical follow-up was performed. Results Combined ChoPET/MR accuracy was 100% for residual tumour, conventional MR accuracy was 96.3% (91.7% &lt;14years, 100% ≥15years) and ChoPET accuracy was 73.1% (66.7% &lt;14years, 80.0% ≥15 years). Lack ack of agreement in 9/27 with ChoPET superior to MR in 1 case. Tumour component analysis demonstrated significantly higher SUVenh and SUVne than SUVwm (SUVenh: p&lt;0.001,SUVne: p=0.003) equivalent to ADC (ADCenh, ADCnenh: p&lt;0.001) and rCBV (rCBVenh, rCBVnenh: p&lt;0,001). Conclusions Combined ChoPET/MR has 100% accuracy in TYA gliomas with suspected disease progression. ChoPET is able to detect enhancing and non-enhancing tumour but it is more reliable for evaluating enhancing disease &gt;15 years. In selected cases where MRI is equivocal, a quantitative multi-modality ChoPET/MR better defines both enhancing and non-enhancing tumour for improved assessment of childhood and TYA gliomas.
Improving multidisciplinary communication during awake craniotomy: First use of a novel robotic exoscope
Authors: Anam Anzak, Alex Alamri, Thomas Doke, Grainne McKenna, Andrew Elsmore, Dimitri Paraskevopoulos, Edward McKintosh
Journal: Neuro-Oncology (2019)

Abstract Background Awake craniotomies require exceptional intra-operative communication between the multidisciplinary team. This is difficult with traditional operating microscopes, where the operative field cannot be visualised by all parties. The Synaptive Modus V is a hands-free, robotic, extracorporeal telescope (exoscope), allowing images to be viewed on multiple large monitors. The Royal London Hospital is the first United Kingdom installation of this device and the first unit in Europe to apply it to awake craniotomies for low-grade glioma. Methods Two consecutive patients with low grade glioma underwent awake craniotomy using the Modus V. Qualitative feedback (semi-structured interview) was received from the MDT including surgeons, occupational/ speech and language/ physio-therapists, neurophysiologists, anaesthetists and scrub team. Optimal device positioning is described. Results Both female patients (38 and 52 years old) underwent surgery between December 2018 and February 2019. Lesions were located in right perisylvian and posterior inferior frontal gyrus locations respectively. Surgical resection was satisfactory. Patient 1 developed a wrist-drop intra-operatively. Patient 2 had transient mild word finding difficulties. Surgeons reported easier surgical flow with hands-free positioning, larger working area and improved ergonomics. Adapting to non-stereoscopic vision increased operating times. Multi-disciplinary team members reported an better communication with the operating surgeon during patient assessment and a more involved educational experience. Conclusion Hands-free exoscopes may provide improved surgical flow and efficiency for awake craniotomy whilst simultaneously improving multidisciplinary communication and education. There is an, as yet, unidentified learning curve for its use that requires learning curve data generation.
Pro72 Allele Potentially Increases the Poor Prognostic Value of p53 Mutations In Chinese Patients with Chronic Lymphocytic Leukemia.
Authors: Huajie Dong, Cheng Fang, Lei Fan, Danxia Zhu, Dongmei Wang, Huayuan Zhu, Yun Zhuang, Kourong Miao, Peng Liu, Wei Xu, Jianyong Li
Journal: Blood (2010)
Early Kinetics of Engraftment Following Reduced-Intensity Stem Cell Transplantation: Fludarabine and Cyclophosphamide Versus Fludarabine and Busulfan.
Authors: Teruhiko Kozuka, Fumihiko Ishimaru, Keitaro Matsuo, Hiromi Nakashima, Nobuharu Fujii, Kenichi Matsuoka, Eisei Kondo, Yoshio Katayama, Yoshinobu Maeda, Katsuji Shinagawa, Kazuma Ikeda, Mitsune Tanimoto
Journal: Blood (2006)
Thymidine Phosphorylase Exerts Complex Effects on Bone Resorption and Formation in Myeloma
Authors: Huan Liu, Zhiqiang Liu, Juan Du, Jin He, Pei Lin, Amini Behrang, Michael W Starbuck, Nora M Novane, Jatin J. Shah, Richard Eric Davis, Jian Hou, Robert Gagel, Jing Yang
Journal: Blood (2016)
Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience
Authors: Rama Nanah, Kristen B. McCullough, William J Hogan, Kebede H. Begna, Naseema Gangat, Mrinal M Patnaik, Michelle Ann Elliott, Mark Litzow, Aref Al-Kali
Journal: Blood (2016)
Interleukin-36γ–producing macrophages drive IL-17–mediated fibrosis
Authors: Sven D. Sommerfeld, Christopher Cherry, Remi M. Schwab, Liam Chung, David R. Maestas, Philippe Laffont, Julie E. Stein, Ada Tam, Sudipto Ganguly, Franck Housseau, Janis M. Taube, Drew M. Pardoll, Patrick Cahan, Jennifer H. Elisseeff
Journal: Science Immunology (2019)

Single-cell RNAseq defines macrophage phenotypes in fibrotic biomaterial environments (see the related Focus by Perciani and MacParland).
A Phase II Randomized Bayesian Study of Very Low Dose Subcutaneous Decitabine Administered Daily or Weekly Times Three in Patients with Lower Risk Myelodysplastic Syndrome (MDS).
Authors: Guillermo Garcia-Manero, Daniel R. Couriel, Francesco Paolo Tambaro, Nashat Gabrail, Ahmed Nadeem, Tapan Kadia, Elias Jabbour, Gautam Borthakur, Stefan Faderl, Willie Newsome, Hui Yang, Kevin Chen, Karen Stein, Hagop Kantarjian
Journal: Blood (2009)
A Phase I Trial of Subcutaneous (SQ) Dose-Escalated Alemtuzumab in Patients with T-Cell Lymphoproliferative Disorders (T-LPD).
Authors: Pierluigi Porcu, Robert A. Baiocchi, Thomas S. Lin, Kristie A. Blum, Patricia Curtis, Grever R. Michael, John C. Byrd
Journal: Blood (2007)
Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)
Authors: Hisayuki Yokoyama, Andreas Lundqvist, Maria Berg, Muthalagu Ramanathan, Rebecca Lopez, Aleah Smith, Nicole Gormley, Su Su, J. Phillip McCoy, Richard W. Childs
Journal: Blood (2008)
AML1-ETO Collaborates with the Homeobox Gene Meis1 in Inducing Acute Leukemia in the Mouse Bone Marrow Transplantation Model.
Authors: Vegi M. Naidu, Vijay P.S. Rawat, Christina Schessl, Konstantin Petropoulus, Monica Cusan, Aniruddha J Deshpande, Leticia Quintanilla Martinez, Wolfgang Hiddemann, Michaela Feuring Buske, Christian Buske
Journal: Blood (2008)
Alemtuzumab Achieved Durable Hematologic Response In Heavily Treated T-Large Granular Lymphocytosis Irrespective To STAT3 Mutation Or V-Beta Clone Size
Authors: Bogdan Dumitriu, Phillip Scheinberg, Sawa Ito, Nicole Stephens, Yunce Muharrem, Emily King, Sachiko Kajigaya, J. Joseph Melenhorst, Fariba Chinian, Keyvan Keyvanfar, Minoo Battiwalla, Pawel Muranski, Neal S. Young, A. John Barrett
Journal: Blood (2013)
Multicenter Validation of the Scoring System of Pre-Transplant Serum Ferritin and Disease Risk in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Takayoshi Tachibana, Masatsugu Tanaka, Estuko Yamazaki, Ayumi Numata, Hirotaka Takasaki, Hideyuki Kuwabara, Katsumichi Fujimaki, Rika Sakai, Hiroyuki Fujita, Shin Fujisawa, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori
Journal: Blood (2011)
Corticosteroid-Free Primary Treatment of Chronic Graft-Versus-Host Disease with Rituximab Results in Excellent Responses and Rapid Time to Immunosuppression Discontinuation
Authors: Connie Sizemore, Michelle Ridgeway, Xu Zhang, Stacey Brown, Lawrence E. Morris, Asad Bashey, H. Kent Holland, Scott R. Solomon
Journal: Blood (2014)
Long-Term Outcomes in Patients with Acute Myelogenous Leukemia (AML) Following Allogeneic Stem Cell Transplantation (AlloSCT) for Relapse After Initial Autologous Bone Marrow Transplant (ASCT).
Authors: Mary-Elizabeth Percival, Lloyd E. Damon, Thomas Martin, Lawrence Kaplan, Weiyun Ai, Jeffrey L. Wolf, Sanghee Hong, Charles Linker, Curt A. Ries, Charalambos Andreadis
Journal: Blood (2009)
ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients
Authors: Mrinal M Patnaik, Raphael Itzykson, Terra L Lasho, Olivier Kosmider, Christy Finke, Curtis A. Hanson, Ryan A Knudson, Rhett P Ketterling, Ayalew Tefferi, Eric Solary
Journal: Blood (2013)
Defective Natural Killer (NK) Receptor Expression and Effector Function in Acute Myeloid Leukemia Partially Normalize At Remission and Predict Response to Chemotherapy.
Authors: Kate Stringaris, Takuye Sekine, Ahmad Khoder, Abdullah Alsuliman, Pavlu Jiri, Anushruthi Sarvaria, David Marin, Jane Apperley, A. John Barrett, Katayoun Rezvani
Journal: Blood (2012)
IFITM3 (CD225) Regulates CD19 Surface Expression and CD19-Mediated Activation of PI3K Signaling in Pre-B Acute Lymphoblastic Leukemia Cells
Authors: Jae-Woong Lee, Huimin Geng, Zhengshan Chen, Eugene Park, Angela Park, Lars Klemm, Charles Bailey, Markus Muschen
Journal: Blood (2014)
Prognostic Relevance of 18F-FDG PET/CT In Newly Diagnosed Multiple Myeloma Patients Treated with up-Front Autologous Transplantation: A Prospective Study
Authors: Elena Zamagni, Cristina Nanni, Francesca Patriarca, Paola Tacchetti, Emanuela Englaro, Giulia Perrone, Silvia Buttignol, Annamaria Brioli, Lucia Pantani, Beatrice Anna Zannetti, Francesca Caroborante, Michele Baccarani, Stefano Fanti, Michele Cavo
Journal: Blood (2010)
Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.
Authors: Takaaki Konuma, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Maki Oiwa-Monna, Kaoru Uchimaru, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano
Journal: Blood (2007)
Interleukin-17 and TH17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications
Authors: Rao H Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Puru Nanjappa, Christine Pai, Saem Lee, Nithya Prabhala, John Daley, Steven P. Treon, Nikhil C. Munshi
Journal: Blood (2010)
Minimal Residual Disease Negative Status At the End of Induction Therapy Is a Potent Prognostic Marker in Adult Non-Ph Acute Lymphoblastic Leukemia: Results of the ALL MRD2002 Study
Authors: Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, Tomohiko Kamimura, Shuichi Taniguchi, Takashi Okamura, Eiichi Ohtsuka, Takashi Yoshida, Masakazu Higuchi, Goichi Yoshimoto, Tomoaki Fujisaki, Yasunobu Abe, Yasushi Takamatsu, Shouhei Yokota, Koichi Akashi, Mine Harada
Journal: Blood (2011)
Combination of Mycophenolate Mofetil with Cyclosporine A and Methotrexate as Gvhd Prophylaxis In Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.
Authors: Xiaoli Zhu, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, He Huang
Journal: Blood (2010)
Network Modeling Reveals CDC42BPA and CLEC11A As Novel Driver Genes of t(4; 14) Multiple Myeloma
Authors: Deepak Perumal, Alessandro Lagana', David Melnekoff, Ben Readhead, Brian Kidd, Violetta V Leshchenko, Pei-Yu Kuo, Jennifer Yesil, Mary Derome, Daniel Auclair, Deepu Madduri, Ajai Chari, Hearn Jay Cho, Bart Barlogie, Sundar Jagannath, Joel Dudley, Samir Parekh
Journal: Blood (2016)
Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.
Authors: Valerie Lapierre, Christian Chabannon, Caroline Makowski, Cecile Dumesnil, Dominique Valteau-Couanet, Anne Vekhoff, Denis Caillot, Nabih Azar, Marine Divine, Karin Blakolmer, Christian Cailliot, Philippe Moreau, Jean-Francois Rossi
Journal: Blood (2007)
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer
Authors: Chen Liang, Si Shi, Yi Qin, Qingcai Meng, Jie Hua, Qiangshen Hu, Shunrong Ji, Bo Zhang, Jin Xu, Xian-Jun Yu
Journal: Gut (2019)

Objective Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive type of GI tumour, and it possesses deregulated cellular energetics. Although recent advances in PDAC biology have led to the discovery of recurrent genetic mutations in Kras , TP53 and SMAD4 , which are related to this disease, clinical application of the molecular phenotype of PDAC remains challenging. Design We combined molecular imaging technology (positron emission tomography/CT) and immunohistochemistry to evaluate the correlation between the maximum standardised uptake value and SMAD4 expression and examined the effect of SMAD4 on glycolysis through in vitro and in vivo experiments. Furthermore, we identified the effect of SMAD4 on metabolic reprogramming by metabolomics and glucose metabolism gene expression analyses. Dual luciferase reporter assays and chromatin immunoprecipitation were performed to identify whether SMAD4 functioned as a transcription factor for phosphoglycerate kinase 1 (PGK1) in PDAC cells. Proliferative and metastatic assays were performed to examine the effect of PGK1 on the malignant behaviour of PDAC. Results We provide compelling evidence that the glycolytic enzyme PGK1 is repressed by transforming growth factor-β/SMAD4. Loss of SMAD4 induces PGK1 upregulation in PDAC, which enhances glycolysis and aggressive tumour behaviour. Notably, in SMAD4-negative PDAC, nuclear PGK1 preferentially drives cell metastasis via mitochondrial oxidative phosphorylation induction, whereas cytoplasmic PGK1 preferentially supports proliferation by functioning as a glycolytic enzyme. The PDAC progression pattern and distinct PGK1 localisation combine to predict overall survival and disease-free survival. Conclusion PGK1 is a decisive oncogene in patients with SMAD4-negative PDAC and can be a target for the development of a therapeutic strategy for SMAD4-negative PDAC.
Comparison of the Sequential High-Dose Chemotherapy Followed by Autologous Stem Cell Support with and without Rituximab in Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma.
Authors: Michal Sieniawski, Jan Oliver Staak, Helena Scheuss, Jan Peter Glossmann, Volker Diehl, Andreas Engert, Andreas Josting
Journal: Blood (2004)
MK-0457, a Novel Multikinase Inhibitor, Is Active in Patients with Chronic Myeloid Leukemia (CML) and Acute Lymphocytic Leukemia (ALL) with the T315I BCR-ABL Resistance Mutation and Patients with Refractory JAK-2 Positive Myeloproliferative Diseases (MPD).
Authors: Francis Giles, Jorge Cortes, Donald A. Bergstrom, Alan Xiao, Dan Jones, Srdan Verstovsek, Deborah Thomas, Hagop M. Kantarjian, Steven J. Freedman
Journal: Blood (2006)
Donor Specific Unresponsiveness Develops Following Loss of Chimerism in Recipients of Haploidentical Combined Bone Marrow/Kidney Transplantation but Not in Recipients of Bone Marrow Transplant Alone.
Authors: Giovanna Andreola, Juanita Shaffer, A. Benedict Cosimi, Tatsuo Kawai, Pete Cotter, Bimalangshu R. Dey, Nina Tolkoff-Rubin, Frederic I. Preffer, Susan Saidman, Kristin Kattleman, David H. Sachs, Thomas R. Spitzer, Megan Sykes
Journal: Blood (2006)
Perivascular Macrophages Regulate Blood Flow Following Tissue Damage
Authors: Evelina Vågesjö, Kristel Parv, David Ahl, Cédric Seignez, Carmen Herrera Hidalgo, Antoine Giraud, Catarina Leite, Olle Korsgren, Håkan Wallén, Greta Juusola, Harri H. Hakovirta, Helene Rundqvist, Magnus Essand, Lena Holm, Randall S. Johnson, Charlotte Thålin, Petra Korpisalo, Gustaf Christoffersson, Mia Phillipson
Journal: Circulation Research (2021)

Rationale: Ischemic injuries remain a leading cause of mortality and morbidity worldwide, and restoration of functional blood perfusion is vital to limit tissue damage and support healing. Objective: To reveal a novel role of macrophages in reestablishment of functional tissue perfusion following ischemic injury that can be targeted to improve tissue restoration. Methods and Results: Using intravital microscopy of ischemic hindlimb muscle in mice, and confocal microscopy of human tissues from amputated legs, we found that macrophages accumulated perivascularly in ischemic muscles, where they expressed high levels of iNOS (inducible nitric oxide [NO] synthase). Genetic depletion of iNOS specifically in macrophages (Cx3cr1-CreERT2;Nos2 fl/fl or LysM-Cre;Nos2 fl/fl ) did not affect vascular architecture but highly compromised blood flow regulation in ischemic but not healthy muscle, which resulted in aggravated ischemic damage. Thus, the ability to upregulate blood flow was shifted from eNOS (endothelial)-dependence in healthy muscles to completely rely on macrophage-derived iNOS during ischemia. Macrophages in ischemic muscles expressed high levels of CXCR4 (C-X-C chemokine receptor type 4) and CCR2 (C-C chemokine receptor type 2), and local overexpression by DNA plasmids encoding the corresponding chemokines CXCL12 (stromal-derived factor 1) or CCL2 (chemokine [C-C motif] ligand 2) increased macrophage numbers, while CXCL12 but not CCL2 induced their perivascular positioning. As a result, CXCL12-overexpression increased the number of perfused blood vessels in the ischemic muscles, improved functional muscle perfusion in a macrophage-iNOS-dependent manner, and ultimately restored limb function. Conclusions: This study establishes a new function for macrophages during tissue repair, as they regulate blood flow through the release of iNOS-produced NO. Further, we demonstrate that macrophages can be therapeutically targeted to improve blood flow regulation and functional recovery of ischemic tissues.
Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).
Authors: Rita Mazza, Stefano Luminari, Massimo Magagnoli, Michele Spina, Teodoro Chisesi, Antonio Pinto, Massimo Federico, Antonella Anastasia, Arturo Chiti, Mariagrazia Michieli, Francesco Angrilli, Luca Castagna, Giampaolo Marcacci, Laura Giordano, Umberto Tirelli, Armando Santoro, Monica Balzarotti
Journal: Blood (2009)
Compound Heterozygosity in the Novel Mutations W157R and T591K in the γ-Glutamyl Carboxylase Gene Causes Hereditary Combined Vitamin K-Dependent Coagulation Factor Deficiency in a Tunisian Family.
Authors: Dhouha Darghouth, Kevin W. Hallgren, Rebecca L. Hain, Amel Mrad, Youssef Gharbi, Ahmed Maherzi, Sophie LeRicousse, Radhia Kastally, Kathleen L. Berkner, Jean-Philippe Rosa
Journal: Blood (2005)
Single Cell Transcriptional Profiling Reveals Activation of TNF-Alpha Signaling in Hematopoietic Stem and Progenitor Cells from Shwachman-Diamond Syndrome Patients
Authors: Cailin Joyce, Assieh Saadatpour, Lan Jiang, Melisa Ruiz-Gutierrez, Ozge Vargel Bolukbasi, Inga Hofmann, Colin A. Sieff, Chad Nusbaum, Akiko Shimamura, Guo-Cheng Yuan, Carl D. Novina
Journal: Blood (2016)
Alteration of Chromatin Modifiers and Misregulation of Transcription Factors Define the Genomic Profile of Infant AML
Authors: Rhonda E. Ries, Hamid Bolouri, Jason E Farrar, Emilia L. Lim, Timothy Junius Triche, Katherine Tarlock, Jaime Guidry Auvil, Betsy A. Hirsch, Susana C. Raimondi, Yussanne Ma, Marco A. Marra, Richard Aplenc, Erin M. Guest, E. Anders Kolb, Alan S. Gamis, Malcolm A. Smith, Daniela S. Gerhard, Soheil Meshinchi
Journal: Blood (2016)
IgA and IgG Hypogammaglobulinemia Does Not Predict for Recurrent Infection Risk and Persists Despite Therapeutic Response in Patients with Waldentrom's Macroglobulinemia.
Authors: Zachary Hunter, Robert Manning, Christina Hanzis, Bryan Ciccarelli, Thea Ioakimidis, Christopher J Patterson, Megan Lewicki, Hsuiyi Tseng, Ping Gong, Xia Liu, Yangsheng Zhou, Guang Yang, Jenny Sun, Lian Xu, Patricia Sheehy, Massimo Morra, Steven Treon
Journal: Blood (2009)
Sarcopenia Determined by Computed Tomography Imaging Is an Independant Prognostic Factor in Elderly Patients with Diffuse Large B CELL Lymphoma Treated by Immunochemotherapy
Authors: Helene Lanic, Jerome Kraut, Romain Modzelewski, jean Michel Picquenot, Mickael Loschi, Aspasia Stamatoullas, Stéphane Leprêtre, Herve Tilly, Fabrice Jardin
Journal: Blood (2012)
Autonomic and Vascular Dysregulation Enhance Pain-Induced Peripheral Vasoconstriction in Sickle Cell Disease
Authors: Patjanaporn Chalacheva, Maha Khaleel, John Sunwoo, Jon A Detterich, Payal Shah, Roberta Miyeko Kato, Wanwara Thuptimdang, Herbert J Meiselman, Richard Sposto, Jennie Tsao, John C Wood, Lonnie Zeltzer, Thomas D. Coates, Michael C.K. Khoo
Journal: Blood (2016)
Phase II Study of Cladribine, Idarubicin, and Cytarabine (araC) in Patients with Acute Myeloid Leukemia (AML)
Authors: Tapan Kadia, Jorge E. Cortes, Elias J. Jabbour, Naval Daver, Naveen Pemmaraju, Farhad Ravandi, Nitin Jain, Srdan Verstovsek, Courtney DiNardo, Yesid Alvarado, Alessandra Ferrajoli, Jan A Burger, Guillermo Garcia-Manero, Maro Ohanian, Marina Konopleva, Zeev Estrov, William Wierda, Mark Brandt, Tina Fitch, Gautam Borthakur, Hagop M. Kantarjian
Journal: Blood (2015)
Activating FLT3 Mutations Display a Wide Range Of Transforming Potential and a Characteristic Pathway Profile Associated With Prognosis In Acute Myeloid Leukemia
Authors: Hanna Janke, Friederike Schneider, Daniela Schumacher, Tobias Herold, Hopfner Karl-Peter, Stephanie Schneider, Wolfgang E. Berdel, Thomas Büchner, Bernhard J. Woermann, Marion Subklewe, Stefan K. Bohlander, Wolfgang Hiddemann, Harald Polzer, Karsten Spiekermann
Journal: Blood (2013)
Contribution of All-Trans Retinoic Acid to Improved Early Relapse-Free Outcome in Infant Acute Lymphoblastic Leukemia Comparing to the Chemotherapy Alone.
Authors: Larisa Fechina, Egor Shorikov, Grigory Tsaur, Leonid Saveliev, Alexander Popov, Olga Aleinikova, Alexander Karachunsky, Alexander Roumyantsev
Journal: Blood (2007)